Alumis ALMS
NASDAQ ALMS
$6.34 -0.21 (-3.13%)
As of: Nov 10, 2026 · 2:50 PM EST

Alumis (ALMS) EBITDA (2023 - 2026)

Updated

Alumis (ALMS) recorded EBITDA of -$95.58 million in Q4 2025, compared with -$97.8 million a year earlier.

Analysis

Alumis (ALMS) EBITDA (2023 - 2026) Analysis & Trends

For FY2025, Alumis reported EBITDA of -$450.31 million.

  • Across earlier years, EBITDA came in at -$297.6 million in FY2024 and -$156.89 million in FY2023.
  • The Q4 2025 figure is the highest quarterly EBITDA since Q2 2024.
  • Per Business Quant, the preceding three quarters came in at -$114.38 million (Q3 2025), -$139.67 million (Q2 2025) and -$100.69 million (Q1 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 13.33 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 8.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 8.16 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 7.37 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn -
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn -
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 4.83 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 4.20 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 7.05 Bn
10 Alumis 830.27 Mn -881.19 Mn - -147.98 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -147.98 Mn
Mar 31, 2026 -97.54 Mn
Dec 31, 2025 -95.58 Mn
Sep 30, 2025 -114.38 Mn
Jun 30, 2025 -139.67 Mn
Mar 31, 2025 -100.69 Mn
Dec 31, 2024 -97.80 Mn
Sep 30, 2024 -97.59 Mn
Jun 30, 2024 -55.38 Mn
Mar 31, 2024 -46.84 Mn
Dec 31, 2023 -39.41 Mn
Sep 30, 2023 -43.44 Mn
API Access

Alumis EBITDA API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebitda&ticker=ALMS&period=max&api_key=YOUR_API_KEY